• Annexin V in Trophoblast–T Cell Apoptosis Assays

  2026-09-10

  Learn how Annexin V, a calcium-dependent phosphatidylserine binding protein, can add a membrane-state readout to trophoblast–T cell and exosome studies. This article translates recent preeclampsia findings into a rigorous apoptosis assay design and interpretation framework.

• Amyloid β-Peptide (1-42): Assay-State Strategy

  2026-09-10

  Explore how Amyloid β-Peptide (1-42) and its aggregation state shape neuronal toxicity, ion-channel responses, and assay interpretation. This guide translates evidence from SH-SY5Y models into a practical, state-aware workflow for Alzheimer’s disease research.

• Sunitinib Workflows for RCC and Angiogenesis

  2026-09-09

  Build reproducible Sunitinib assays for receptor signaling, renal cell carcinoma, apoptosis, cell-cycle analysis, and tumor angiogenesis. This guide combines practical dosing and formulation advice with a combination-testing framework inspired by recent research on overcoming Sunitinib resistance.

• FPS-ZM1: A RAGE Inhibitor Assay Workflow

  2026-09-09

  Build a receptor-focused workflow with FPS-ZM1 to separate RAGE-dependent amyloid beta signaling, neuronal stress, and neuroinflammation from broader metabolic effects. The guide translates emerging RAGE/POMC findings into practical controls, solvent handling, readouts, and troubleshooting decisions.

• Rotigotine’s Antidepressant Properties in Depression Models

  2026-09-08

  The reference study evaluated Rotigotine across anxiety, behavioral despair, learned helplessness, and olfactory bulbectomy models, providing one of the early systematic examinations of antidepressant-like effects from a dopamine agonist. Its central practical insight is that apparent behavioral improvement must be separated from nonspecific motor stimulation, particularly at higher doses.

• Dual Luciferase Reporter Gene System for MRF Studies

  2026-09-08

  Use a normalized two-reporter design to test how MRF, FSHR, and cAMP–PKA–CREB signaling influence BMSC transcription. The workflow combines direct-addition detection, practical controls, and troubleshooting guidance for reproducible promoter and pathway experiments.

• Quercetin, Hippo Signaling, and Cataract Protection

  2026-09-07

  The reference study combines network pharmacology with mouse and lens epithelial-cell experiments to identify Hippo pathway suppression as a mechanism associated with quercetin-mediated cataract protection. Its results connect quercetin with lower oxidative stress, improved epithelial-cell survival, and increased proliferation, while α-hederin reverses several of these effects and provides pharmacological support for pathway involvement.

• Flumequine in Reliable Topoisomerase II Assays

  2026-09-07

  Learn how Flumequine (SKU B2292) can improve interpretation of viability, proliferation, and cytotoxicity experiments by separating formulation variables from biological effects. This scenario-driven guide connects its documented topoisomerase II inhibition, solubility, purity, and storage properties with practical assay design.

• Ertapenem: A Functional Lens on Resistance

  2026-09-05

  Explore how Ertapenem sodium salt can connect carbapenem resistance genotypes with measurable bacterial phenotypes. This evidence-led guide translates recent CREC transmission findings into practical assay design, controls, and interpretation for antibiotic resistance research.

• Nicotinamide Riboside Chloride in RGC Models

  2026-09-04

  Nicotinamide Riboside Chloride (NIAGEN) offers a practical way to test NAD+ biology alongside reproducible iPSC-derived retinal ganglion cell workflows. This guide connects metabolic readouts, RGC identity assays, and troubleshooting strategies without overstating an exploratory cross-domain application.

• ABT-199: A Heterogeneity-Aware Apoptosis Strategy

  2026-09-04

  ABT-199 (Venetoclax) is more than a selective Bcl-2 inhibitor: it can serve as a mechanistic probe for distinguishing Bcl-2 dependence from generalized cytotoxicity. This article connects mitochondrial apoptosis pathway biology with the AR-heterogeneity framework reported in prostate cancer research to improve model selection and assay interpretation.

• Nystatin (Fungicidin) in Antifungal Assays

  2026-09-03

  Nystatin (Fungicidin) provides a membrane-targeted benchmark for Candida susceptibility, adhesion, and formulation studies. Its carefully controlled use also creates a valuable negative control in cell-entry experiments, as shown by the grass carp reovirus study.

• AZD8055: Practical mTOR Inhibitor Workflow

  2026-09-03

  AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 signaling, mTORC2 signaling, cancer cell proliferation, and metabolism. This dossier-based guide covers preparation, assay setup, QC, and interpretation, while defining why the compound should not be used to infer clinical efficacy or replace model-specific optimization.

• Difloxacin HCl: Applied Research Workflows

  2026-09-02

  Difloxacin HCl supports two distinct bench applications: quantitative antimicrobial susceptibility testing and exploratory multidrug resistance reversal studies. This guide connects formulation, assay design, controls, and troubleshooting while clearly separating product-supported use cases from the mitotic checkpoint mechanism described in the reference study.

• (R,S)-Anatabine: A Cross-Domain Research Lens

  2026-09-02

  Explore how (R,S)-Anatabine can dissect amyloidogenic processing and inflammatory signaling in Alzheimer’s models. This article adds a cross-domain assay framework informed by recent advances in epidermal barrier biology, while separating established evidence from future research hypotheses.

8048 records 1/537 page Next 12345 下5页 Last page